LymphedemaV1, Main, Exploration, bibRecord, 001222

Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?

Identifieur interne : 001222 ( Main/Exploration ); précédent : 001221; suivant : 001223

Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?

Auteurs : Ioannis D. Bassukas [Grèce] ; Ioannis Chaniotakis [Grèce] ; Georgios Gaitanis [Grèce]

Source :

Dermatology and Therapy [ 2193-8210 ] ; 2016.

RBID : PMC:4799042

Abstract

Introduction

Cellulitis recurrences are frequent, difficult to manage, and contribute considerably to overall disease burden. This retrospective cases series reports recurrence rates of first community-acquired lower limb disease episode initially treated with daptomycin.

Methods

Treatment consisted of a 21-day two substances sequential scheme: intravenous daptomycin (4 mg/kg/day) during hospitalization and roxithromycin (2 × 150 mg per os) afterwards. Primary study end-point was the rate of recurrences during follow-up; recurrence rates and their binomial 95% confidence intervals (CI) were calculated with SPSS 22.0. Recurrences were identified by (1) review of hospital records and (2) telephone questionnaires.

Results

Twenty-seven patients hospitalized for first lower limb cellulitis episodes were started on daptomycin and 26 patients completed the above three-week sequential treatment scheme. During follow-up (range 37–85 months) one recurrence occurred among the 26 patients who completed the treatment: 96.2% of these patients remained relapse free at the end of follow-up (CI 79.5–99.9%). Considering also treatment failure, the overall effectiveness of this combination treatment was 92.6% recurrence free after more than 3 years follow-up (25/27 patients; CI 75.5–99.0%). This study is limited by retrospective planning and the restricted number of included patients.

Conclusion

The choice of the treatment for the initial lower limb cellulitis episode may impact the risk of disease recurrences. Future studies should explore interventions for the first cellulitis episode as a means to modify the risk of the recurring course of this disease.

Electronic supplementary material

The online version of this article (doi:10.1007/s13555-016-0095-8) contains supplementary material, which is available to authorized users.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799042

DOI: 10.1007/s13555-016-0095-8
PubMed: 26838583
PubMed Central: 4799042

Affiliations:

Grèce

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?</title>
<author><name sortKey="Bassukas, Ioannis D" sort="Bassukas, Ioannis D" uniqKey="Bassukas I" first="Ioannis D." last="Bassukas">Ioannis D. Bassukas</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece</nlm:aff>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chaniotakis, Ioannis" sort="Chaniotakis, Ioannis" uniqKey="Chaniotakis I" first="Ioannis" last="Chaniotakis">Ioannis Chaniotakis</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece</nlm:aff>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gaitanis, Georgios" sort="Gaitanis, Georgios" uniqKey="Gaitanis G" first="Georgios" last="Gaitanis">Georgios Gaitanis</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece</nlm:aff>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">26838583</idno>
<idno type="pmc">4799042</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799042</idno>
<idno type="RBID">PMC:4799042</idno>
<idno type="doi">10.1007/s13555-016-0095-8</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">000A39</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000A39</idno>
<idno type="wicri:Area/Pmc/Curation">000A38</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000A38</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000A76</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000A76</idno>
<idno type="wicri:Area/Ncbi/Merge">007E30</idno>
<idno type="wicri:Area/Ncbi/Curation">007E30</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">007E30</idno>
<idno type="wicri:doubleKey">2193-8210:2016:Bassukas I:daptomycin:based:week</idno>
<idno type="wicri:Area/Main/Merge">001224</idno>
<idno type="wicri:Area/Main/Curation">001222</idno>
<idno type="wicri:Area/Main/Exploration">001222</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?</title>
<author><name sortKey="Bassukas, Ioannis D" sort="Bassukas, Ioannis D" uniqKey="Bassukas I" first="Ioannis D." last="Bassukas">Ioannis D. Bassukas</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece</nlm:aff>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chaniotakis, Ioannis" sort="Chaniotakis, Ioannis" uniqKey="Chaniotakis I" first="Ioannis" last="Chaniotakis">Ioannis Chaniotakis</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece</nlm:aff>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gaitanis, Georgios" sort="Gaitanis, Georgios" uniqKey="Gaitanis G" first="Georgios" last="Gaitanis">Georgios Gaitanis</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece</nlm:aff>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Dermatology and Therapy</title>
<idno type="ISSN">2193-8210</idno>
<idno type="eISSN">2190-9172</idno>
<imprint><date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Introduction</title>
<p>Cellulitis recurrences are frequent, difficult to manage, and contribute considerably to overall disease burden. This retrospective cases series reports recurrence rates of first community-acquired lower limb disease episode initially treated with daptomycin.</p>
</sec>
<sec><title>Methods</title>
<p>Treatment consisted of a 21-day two substances sequential scheme: intravenous daptomycin (4 mg/kg/day) during hospitalization and roxithromycin (2 × 150 mg per os) afterwards. Primary study end-point was the rate of recurrences during follow-up; recurrence rates and their binomial 95% confidence intervals (CI) were calculated with SPSS 22.0. Recurrences were identified by (1) review of hospital records and (2) telephone questionnaires.</p>
</sec>
<sec><title>Results</title>
<p>Twenty-seven patients hospitalized for first lower limb cellulitis episodes were started on daptomycin and 26 patients completed the above three-week sequential treatment scheme. During follow-up (range 37–85 months) one recurrence occurred among the 26 patients who completed the treatment: 96.2% of these patients remained relapse free at the end of follow-up (CI 79.5–99.9%). Considering also treatment failure, the overall effectiveness of this combination treatment was 92.6% recurrence free after more than 3 years follow-up (25/27 patients; CI 75.5–99.0%). This study is limited by retrospective planning and the restricted number of included patients.</p>
</sec>
<sec><title>Conclusion</title>
<p>The choice of the treatment for the initial lower limb cellulitis episode may impact the risk of disease recurrences. Future studies should explore interventions for the first cellulitis episode as a means to modify the risk of the recurring course of this disease.</p>
</sec>
<sec><title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1007/s13555-016-0095-8) contains supplementary material, which is available to authorized users.</p>
</sec>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Stevens, Dl" uniqKey="Stevens D">DL Stevens</name>
</author>
<author><name sortKey="Bisno, Al" uniqKey="Bisno A">AL Bisno</name>
</author>
<author><name sortKey="Chambers, Hf" uniqKey="Chambers H">HF Chambers</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Chaniotakis, I" uniqKey="Chaniotakis I">I Chaniotakis</name>
</author>
<author><name sortKey="Gaitanis, G" uniqKey="Gaitanis G">G Gaitanis</name>
</author>
<author><name sortKey="Skandalis, K" uniqKey="Skandalis K">K Skandalis</name>
</author>
<author><name sortKey="Alexis, I" uniqKey="Alexis I">I Alexis</name>
</author>
<author><name sortKey="Bassukas, Id" uniqKey="Bassukas I">ID Bassukas</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Horseman, M" uniqKey="Horseman M">M Horseman</name>
</author>
<author><name sortKey="Bowman, Jd" uniqKey="Bowman J">JD Bowman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Mcnamara, Dr" uniqKey="Mcnamara D">DR McNamara</name>
</author>
<author><name sortKey="Tleyjeh, Im" uniqKey="Tleyjeh I">IM Tleyjeh</name>
</author>
<author><name sortKey="Berbari, Ef" uniqKey="Berbari E">EF Berbari</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Arbeit, Rd" uniqKey="Arbeit R">RD Arbeit</name>
</author>
<author><name sortKey="Maki, D" uniqKey="Maki D">D Maki</name>
</author>
<author><name sortKey="Tally, Fp" uniqKey="Tally F">FP Tally</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Seaton, Ra" uniqKey="Seaton R">RA Seaton</name>
</author>
<author><name sortKey="Barr, Da" uniqKey="Barr D">DA Barr</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Cox, Nh" uniqKey="Cox N">NH Cox</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Carlson, Ja" uniqKey="Carlson J">JA Carlson</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Komatsu, Y" uniqKey="Komatsu Y">Y Komatsu</name>
</author>
<author><name sortKey="Okazaki, A" uniqKey="Okazaki A">A Okazaki</name>
</author>
<author><name sortKey="Hirahara, K" uniqKey="Hirahara K">K Hirahara</name>
</author>
<author><name sortKey="Araki, K" uniqKey="Araki K">K Araki</name>
</author>
<author><name sortKey="Shiohara, T" uniqKey="Shiohara T">T Shiohara</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations><list><country><li>Grèce</li>
</country>
</list>
<tree><country name="Grèce"><noRegion><name sortKey="Bassukas, Ioannis D" sort="Bassukas, Ioannis D" uniqKey="Bassukas I" first="Ioannis D." last="Bassukas">Ioannis D. Bassukas</name>
</noRegion>
<name sortKey="Chaniotakis, Ioannis" sort="Chaniotakis, Ioannis" uniqKey="Chaniotakis I" first="Ioannis" last="Chaniotakis">Ioannis Chaniotakis</name>
<name sortKey="Gaitanis, Georgios" sort="Gaitanis, Georgios" uniqKey="Gaitanis G" first="Georgios" last="Gaitanis">Georgios Gaitanis</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001222 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001222 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4799042
   |texte=   Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26838583" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?

Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.